Skip to main content
Beta Drugs Limited logo

Beta Drugs Limited — Investor Relations & Filings

Ticker · BETA ISIN · INE351Y01019 LEI · 984500A89888DB9E6T57 National Stock Exchange of India Manufacturing
Open in API
Filings indexed 431 across all filing types
Latest filing 2019-05-01 Board/Management Inform…
Country IN India
Listing National Stock Exchange of India BETA

About Beta Drugs Limited

https://www.betadrugslimited.com

Beta Drugs Limited specializes in the development, manufacture, and marketing of oncology formulations. The company provides a comprehensive portfolio of anti-cancer drugs across various therapeutic segments, including cytotoxic injectables, lyophilized products, tablets, and capsules. Its manufacturing capabilities encompass a wide range of oncology treatments such as chemotherapy agents and supportive care medications. The organization operates advanced production facilities designed to meet international quality standards, focusing on high-potency active pharmaceutical ingredients and finished dosage forms. The company serves diverse markets through its own branded products and contract manufacturing services, aiming to provide affordable and high-quality cancer care solutions. Its core competency lies in its specialized focus on the oncology niche and its integrated approach to pharmaceutical production.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Board/Management Information Classification · 95% confidence The document is a detailed announcement from Beta Drugs Limited regarding the outcome of a Board of Directors meeting held on May 1, 2019. It includes approvals for appointments of auditors (cost auditor, secretarial auditor, internal auditor) for the financial year 2019-20 and approval of allotment of equity shares under preferential issue. The document contains detailed profiles of the appointed auditors and their qualifications and experience. There is no indication that this is a full annual report or financial statement. Instead, it is an official announcement of board decisions related to appointments and share allotment. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management and related approvals. The document length (10,386 characters) and content confirm it is not a brief announcement or a report publication notice. Therefore, the classification is MANG with high confidence.
2019-05-01 English
Outcome of Board Meeting
Board/Management Information Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India Limited reporting the outcome of a Board of Directors meeting held on May 1, 2019. It details approvals made during the meeting, including appointments of auditors (cost auditor, secretarial auditor, internal auditor) and approval of a preferential share allotment. The content focuses on board decisions and appointments rather than financial results or detailed reports. The document length is short (1884 characters), and it is an announcement of board meeting outcomes rather than a full report. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management and related decisions.
2019-05-01 English
Board Meeting — Other business matters
Board/Management Information Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India Limited, informing about a forthcoming Board Meeting scheduled for May 1, 2019. The letter outlines agenda items such as appointment of auditors and approval of share allotment. It is a notification about a board meeting rather than the meeting materials or minutes themselves. The document is short (1572 characters) and serves as an announcement of an upcoming event related to board activities. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes or meetings involving the company's board or senior management.
2019-04-26 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice regarding an investor/analyst meeting held by Beta Dru Limited, referencing compliance with SEBI Listing Obligations and Disclosure Requirements. It mentions the date and location of the meeting and states that the discussion was based on publicly available information. The document is only 1421 characters long and does not contain any financial statements or detailed financial data. It is an announcement of an event rather than a full report or transcript. Therefore, it fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2019-04-24 English
Shareholders meeting
Regulatory Filings Classification · 95% confidence The document is titled as minutes of an Extraordinary General Meeting (EGM) held on April 22, 2019. It details the attendance of directors and members, the election of the chairman, and the special business conducted, which is the issue of equity shares on a preferential basis to a non-promoter. The document includes the resolution text, references to relevant laws and regulations (Companies Act 2013, ICDR Regulations), and the voting results. It is a formal record of the meeting proceedings and resolutions passed, not a financial report or announcement of results. This fits the category of a shareholder meeting minutes document, which is best classified under Regulatory Filings (RNS) as it does not fit other more specific categories like AGM Information (which is for Annual General Meetings) or Capital/Financing Update (which would be more about announcements rather than minutes). The document length (9085 characters) and content confirm it is a full minutes document, not a brief announcement or proxy solicitation. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2019-04-23 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed disclosure of the outcome of an Extraordinary General Meeting (EGM) held on April 22, 2019, by Beta Drugs Limited. It includes the proceedings of the meeting, resolutions passed (notably the issue of equity shares on a preferential basis), voting results, and compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. The content is focused on the announcement of the meeting's outcome and voting results rather than the meeting materials or proxy statements. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length and detail confirm it is not a brief announcement or a proxy solicitation but a full disclosure of voting results and meeting outcome.
2019-04-22 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.